Crossmark

Frailty is an independent factor for health-related quality of life in patients with head and neck cancer receiving definitive concurrent chemoradiotherapy

Crossref DOI link: https://doi.org/10.1007/s00520-024-08313-9

Published Online: 2024-01-15

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Chang-Hsien

Hung, Chia-Yen

Hsueh, Shun-Wen

Yeh, Kun-Yun

Hung, Yu-Shin

Chou, Wen-Chi
Funding

Funding for this research was provided by:

Chang Gung Medical Foundation (CMRPG3L1611)

Chang Gung Memorial Hospital, Linkou (CORPG3N0151)

Ministry of Health and Welfare (MOHW112-TDU-B-222-124011)

National Science and Technology Council, Taiwan, R.O.C. (NSTC 111-2314-B-182A-162)
License Information

Text and Data Mining valid from 2024-01-15

Version of Record valid from 2024-01-15
More Information

Article History

Received: 6 October 2023

Accepted: 8 January 2024

First Online: 15 January 2024

Declarations

:

: The protocol for this research project has been approved by the suitably constituted Institutional Review Board (approval no. 201600916B0) and it conforms to the provisions of the 2013 Declaration of Helsinki. All informed consent was obtained from the subject(s).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below